Core Viewpoint - Viewbix Inc. is set to acquire a significant stake in Quantum X Labs, a leading quantum technology laboratory in Israel, marking a strategic move to enhance its position in the rapidly evolving quantum technology sector [1][6]. Group 1: Acquisition Details - Viewbix has signed a definitive agreement to acquire up to 100% of Quantum X Labs, with a minimum of 85% stake, expected to close within 90 days from December 15, 2025, pending regulatory approvals and stockholder consent [1][6]. - The acquisition is anticipated to provide Viewbix with access to Quantum X Labs' expanding patent portfolio, including innovations in quantum error correction [6]. Group 2: Quantum X Labs Overview - Quantum X Labs is recognized for its interdisciplinary approach, uniting top-tier talent and research from prestigious Israeli institutions, positioning itself as a cornerstone of Israel's quantum sector [2]. - The laboratory operates five portfolio companies, each addressing unique quantum challenges, which enhances synergy and reduces risks across its initiatives [3]. Group 3: Market Potential - The timing of the acquisition aligns with the maturation of quantum computing, with markets such as personalized medicine and secure communications expected to experience significant growth [4]. - Quantum X Labs holds a strong intellectual property portfolio, including multiple upcoming patent filings, which positions it to capture substantial value in the burgeoning quantum sector [5].
Viewbix Spotlights Quantum X Labs – Israel's Multi-Disciplinary Quantum Hub